YY/T 1874-2023Active implantable medical devices - Electromagnetic compatibility - EMC test protocols for implantable cardiac pacemakers, implantable cardioverter defibrillators and cardiac resynchronization devices (English PDF)
有源植入式医疗器械 电磁兼容 植入式心脏起搏器、植入式心律转复除颤器和心脏再同步器械的电磁兼容试验方案
This is a limited preview
Buy now to download the full PDF (117 pages)
Need quotation for your management?
Get a formal quotation for YY/T 1874-2023 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
March 14, 2023
Implementation date
May 1, 2024
Scope
YY/T 1874-2023 is the English-translated version of 有源植入式医疗器械 电磁兼容 植入式心脏起搏器、植入式心律转复除颤器和心脏再同步器械的电磁兼容试验方案.
YY/T 1874-2023 is the Chinese standard "Active implantable medical devices - Electromagnetic compatibility - EMC test protocols for implantable cardiac pacemakers, implantable cardioverter defibrillators and cardiac resynchronization devices".
Its scope clause reads: This document specifies procedures for the evaluation of one or more of the bradycardia, tachycardia, and cardiac Electromagnetic compatibility (EMC) test methods for active implantable cardiovascular devices for resynchronization and other treatments: NOTE: This document is designed for pulse generators used with endocardial leads or epicardial leads: For those who do not use endocardial or epicardial electrocardiography Pulse generators using polar lead technology, adjusted at the discretion of the manufacturer using these technologies: This document specifies performance limits for such devices when interacting with EM transmitters that may operate in the following two EM spectral ranges: ---0Hz<=f< 385MHz; ---385MHz<=f<=3000MHz: This document also specifies the requirements for the protection of such devices from EM fields in medical environments, defines the required accompanying documents, and provides information about EM transmitter manufacturers and expected immunity levels: This document applies to transvenous lead systems that can provide one or more of bradycardia, tachycardia, and cardiac resynchronization, etc: Therapeutic Active Implantable Cardiovascular Devices:.
Found what you need?
Document preview — YY/T 1874-2023
National Standard of the People's Republic of China
- ICS
- 11.040.40
- Classification
- C35
Issued by: National Medical Products Administration
Contents
- Preface
- Introduction
- 1 Scope
- 2 Normative references
- 3 Terms and Definitions
- 4 0Hz<=f<=3000MHz frequency band test requirements
- 5 Tests with frequencies higher than 3000 MHz
- 6 Protection of devices from electromagnetic fields in therapeutic environments
- 7 Other accompanying documents
- Appendix A (Informative) Principle
- Appendix B (Informative) Principles of Test Frequency Range
- Appendix D (Normative) Interface Circuit
- Appendix E (Informative) Selection of Capacitor Cx
- Appendix F (Normative) Calibration of injection network (Figure D:5)
- Appendix G (Normative) Torso Simulator
- Appendix H (Normative) Dipole Antenna
- Appendix I (Normative) Pacemaker/ICD Program Control Settings
- Appendix J (Normative) Simulated Heart Signal
- Appendix K (Normative) Calculation of Net Power of Dipole Antenna
- Appendix L (informative) loop area calculation
- Appendix M (informative) Correlation between test voltage levels and radiated field strengths used in this document
- Appendix N (informative) Connection with DUT with more than two electrode connection ports
- References
1 Scope
This document specifies procedures for the evaluation of one or more of the bradycardia, tachycardia, and cardiac
Electromagnetic compatibility (EMC) test methods for active implantable cardiovascular devices for resynchronization and other treatments:
NOTE: This document is designed for pulse generators used with endocardial leads or epicardial leads: For those who do not use endocardial or epicardial electrocardiography
Pulse generators using polar lead technology, adjusted at the discretion of the manufacturer using these technologies:
This document specifies performance limits for such devices when interacting with EM transmitters that may operate in the following two EM spectral ranges:
---0Hz<=f< 385MHz;
---385MHz<=f<=3000MHz:
This document also specifies the requirements for the protection of such devices from EM fields in medical environments, defines the required accompanying documents, and provides information about EM transmitter manufacturers and expected immunity levels:
This document applies to transvenous lead systems that can provide one or more of bradycardia, tachycardia, and cardiac resynchronization, etc:
Therapeutic Active Implantable Cardiovascular Devices:
2 Normative references
The contents of the following documents constitute the essential provisions of this document through normative references in the text: Among them, dated references,
Only the version corresponding to the date applies to this document; for undated references, the latest version (including all amendments) applies to this document:
ISO 14708-1:2014 Surgical implants Active implantable medical devices Part 1: General requirements for safety, marking and information provided by the manufacturer
Note: GB 16174:1-2015 Surgical implants Active implantable medical devices Part 1: General requirements for safety, marking and information provided by the manufacturer (ISO 4708-1:2000, IDT)
ISO 14708-2:2019 Surgical implants Active implantable medical devices Part 2: Cardiac pacemakers
Note: GB 16174:2-2015 Surgical Implants Active Implantable Medical Devices Part 2: Cardiac Pacemakers (ISO 14708-2:2005, IDT)
ISO 14708-6:2019 Surgical implants Active implantable medical devices Part 6: Active devices for the treatment of tachyarrhythmias
Note: YY 0989:6-2016 Active implantable medical devices for surgical implants Part 6: Active implantable medical devices for the treatment of tachyarrhythmias (including implantable defibrillators) specific requirements (ISO 14708-6:2010, IDT) […]
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 117 pages — is available in the English PDF.
Referenced standards
Normative references
ISO 14708 · GB 16174 · ISO 4708 · YY 0989
Cited by
- YY 0989.6-2025Implants for surgery - Active implantable medical devices - Part 6: Particular requirements for active implantable medical devices intended to treat tachyarrhythmia (including implantable defibrillators)
- GB 16174.2-2024Implants for surgery - Active implantable medical devices - Part 2: Cardiac pacemakers
- GB 16174.2-2015Implants for surgery - Active implantable medical devices - Part 2: Cardiac pacemakers
Similar standards
How to Download YY/T 1874-2023
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB 16174.1-2015 — Implants for surgery—Active implantable medical devices—Part 1: General requirements for safety, marking and for information to be provided by the manufacturer
GB 16174.1-2024 — Implants for surgery - Active implantable medical devices - Part 1: General requirements for safety, marking and for information to be provided by the manufacturer
GB 16174.2-2015 — Implants for surgery - Active implantable medical devices - Part 2: Cardiac pacemakers
Secure payment via Stripe
Payments accepted
YY/T 1874-2023
$1,595.00